Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
You must be logged in to use this feature
{{ loginError }}
Select categories you would like to watch. Updates to this gene will be sent to {{ username }}
x
Send Message
Gene: Dnajc19 (DnaJ heat shock protein family (Hsp40) member C19) Rattus norvegicus
Analyze
Symbol:
Dnajc19
Name:
DnaJ heat shock protein family (Hsp40) member C19
RGD ID:
1560220
Description:
Predicted to enable ATPase activator activity. Predicted to be involved in several processes, including protein import into mitochondrial matrix; regulation of cardiolipin metabolic process; and visual perception. Predicted to be located in matrix side of mitochondrial inner membrane. Predicted to be part of PAM complex, Tim23 associated import motor. Human ortholog(s) of this gene implicated in 3-methylglutaconic aciduria type 5. Orthologous to human DNAJC19 (DnaJ heat shock protein family (Hsp40) member C19); PARTICIPATES IN presequence pathway of mitochondrial protein import; INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
DnaJ (Hsp40) homolog, subfamily C, member 19; hypothetical protein LOC502525; LOC502525; mitochondrial import inner membrane translocase subunit TIM14; RGD1560220; similar to homolog of yeast TIM14 isoform c; similar to translocase of the inner mitochondrial membrane 14 isoform a; uncharacterized protein LOC502525
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 118,851,497 - 118,875,813 (-) NCBI GRCr8 GRCr8 GRCr8 GRCr8 Ensembl 2 118,869,413 - 118,873,781 (-) Ensembl GRCr8 mRatBN7.2 2 116,923,272 - 116,945,312 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 116,923,272 - 116,945,264 (-) Ensembl mRatBN7.2 UTH_Rnor_SHR_Utx 2 123,512,875 - 123,534,874 (-) NCBI UTH_Rnor_SHR_Utx UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 121,625,542 - 121,647,543 (-) NCBI UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 116,253,290 - 116,275,296 (-) NCBI UTH_Rnor_WKY_Bbb_1.0 UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 120,503,093 - 120,531,782 (+) NCBI Rnor_6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 120,504,130 - 120,531,782 (+) Ensembl rn6 Rnor6.0 Rnor_5.0 2 140,149,956 - 140,174,575 (+) NCBI Rnor_5.0 Rnor_5.0 rn5 Celera 2 111,962,564 - 111,984,600 (-) NCBI Celera Cytogenetic Map 2 q24 NCBI
JBrowse:
Imported Disease Annotations - ClinVar
Imported Disease Annotations - CTD
Imported Disease Annotations - OMIM
Only show annotations with direct experimental evidence (0 objects hidden)
Dnajc19 Rat (+)-dexrazoxane decreases expression ISO Dnajc19 (Mus musculus) 6480464 Dexrazoxane results in decreased expression of DNAJC19 mRNA CTD PMID:26873546 Dnajc19 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DNAJC19 mRNA] CTD PMID:31150632 Dnajc19 Rat (-)-epigallocatechin 3-gallate decreases expression ISO DNAJC19 (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of DNAJC19 mRNA CTD PMID:22079256 Dnajc19 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJC19 mRNA CTD PMID:22079256 Dnajc19 Rat (1->4)-beta-D-glucan multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DNAJC19 mRNA CTD PMID:36331819 Dnajc19 Rat 1,1-dichloroethene decreases expression ISO Dnajc19 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of DNAJC19 mRNA CTD PMID:26682919 Dnajc19 Rat 1,2-dimethylhydrazine multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DNAJC19 mRNA CTD PMID:22206623 Dnajc19 Rat 1,2-dimethylhydrazine decreases expression ISO Dnajc19 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in decreased expression of DNAJC19 mRNA CTD PMID:22206623 Dnajc19 Rat 17alpha-ethynylestradiol affects expression ISO Dnajc19 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of DNAJC19 mRNA CTD PMID:17555576 Dnajc19 Rat 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Dnajc19 (Mus musculus) 6480464 2,2',4,4'-tetrabromodiphenyl ether affects the expression of DNAJC19 mRNA CTD PMID:30294300 Dnajc19 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Dnajc19 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DNAJC19 mRNA CTD PMID:21570461 Dnajc19 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DNAJC19 mRNA CTD PMID:33387578 Dnajc19 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Dnajc19 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of DNAJC19 mRNA CTD PMID:21354282 Dnajc19 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Dnajc19 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of DNAJC19 mRNA CTD PMID:25172293 Dnajc19 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Dnajc19 Rat 4,4'-sulfonyldiphenol increases expression ISO Dnajc19 (Mus musculus) 6480464 bisphenol S results in increased expression of DNAJC19 mRNA CTD PMID:39298647 Dnajc19 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Dnajc19 Rat 4,4'-sulfonyldiphenol affects methylation ISO DNAJC19 (Homo sapiens) 6480464 bisphenol S affects the methylation of DNAJC19 gene CTD PMID:31601247 Dnajc19 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DNAJC19 mRNA CTD PMID:30047161 Dnajc19 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of DNAJC19 mRNA CTD PMID:31881176 Dnajc19 Rat aflatoxin B1 decreases methylation ISO DNAJC19 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of DNAJC19 gene CTD PMID:27153756 Dnajc19 Rat all-trans-retinoic acid decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Tretinoin results in decreased expression of DNAJC19 mRNA CTD PMID:33167477 Dnajc19 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of DNAJC19 mRNA CTD PMID:30047161 Dnajc19 Rat aristolochic acid A decreases expression ISO DNAJC19 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of DNAJC19 mRNA CTD PMID:33212167 Dnajc19 Rat arsane multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DNAJC19 more ... CTD PMID:32525701|PMID:39836092 Dnajc19 Rat arsenic atom multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DNAJC19 more ... CTD PMID:32525701|PMID:39836092 Dnajc19 Rat atrazine decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Atrazine results in decreased expression of DNAJC19 mRNA CTD PMID:22378314 Dnajc19 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Dnajc19 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of DNAJC19 mRNA CTD PMID:34319233|PMID:35550907 Dnajc19 Rat bis(2-ethylhexyl) phthalate increases expression ISO Dnajc19 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of DNAJC19 mRNA CTD PMID:33754040 Dnajc19 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DNAJC19 mRNA CTD PMID:25181051 Dnajc19 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Dnajc19 Rat bisphenol A increases expression ISO Dnajc19 (Mus musculus) 6480464 bisphenol A results in increased expression of DNAJC19 mRNA CTD PMID:32156529 Dnajc19 Rat bisphenol A multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Dnajc19 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Dnajc19 Rat cadmium atom multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC19 more ... CTD PMID:37236586 Dnajc19 Rat cadmium dichloride decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of DNAJC19 mRNA CTD PMID:38382870 Dnajc19 Rat cadmium dichloride multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC19 more ... CTD PMID:37236586 Dnajc19 Rat carbon nanotube increases expression ISO Dnajc19 (Mus musculus) 6480464 Nanotubes, Carbon analog results in increased expression of DNAJC19 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 Dnajc19 Rat chenodeoxycholic acid multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Dnajc19 Rat choline multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Dnajc19 Rat copper(II) sulfate decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of DNAJC19 mRNA CTD PMID:19549813 Dnajc19 Rat corosolic acid decreases expression ISO DNAJC19 (Homo sapiens) 6480464 corosolic acid results in decreased expression of DNAJC19 mRNA CTD PMID:37939859 Dnajc19 Rat cyclosporin A decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of DNAJC19 mRNA CTD PMID:25562108 Dnajc19 Rat cyclosporin A multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Dnajc19 Rat deoxycholic acid multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Dnajc19 Rat dexamethasone multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Dnajc19 Rat Dibutyl phosphate affects expression ISO DNAJC19 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of DNAJC19 mRNA CTD PMID:37042841 Dnajc19 Rat dibutyl phthalate decreases expression ISO Dnajc19 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of DNAJC19 mRNA CTD PMID:21266533 Dnajc19 Rat dicrotophos decreases expression ISO DNAJC19 (Homo sapiens) 6480464 dicrotophos results in decreased expression of DNAJC19 mRNA CTD PMID:28302478 Dnajc19 Rat doxorubicin decreases expression ISO Dnajc19 (Mus musculus) 6480464 Doxorubicin results in decreased expression of DNAJC19 mRNA CTD PMID:26873546 Dnajc19 Rat doxorubicin decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of DNAJC19 mRNA CTD PMID:29803840 Dnajc19 Rat fenofibrate multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of DNAJC19 mRNA CTD PMID:21318169 Dnajc19 Rat fenofibrate increases expression ISO Dnajc19 (Mus musculus) 6480464 Fenofibrate results in increased expression of DNAJC19 mRNA CTD PMID:21318169 Dnajc19 Rat fenthion increases expression ISO Dnajc19 (Mus musculus) 6480464 Fenthion results in increased expression of DNAJC19 mRNA CTD PMID:34813904 Dnajc19 Rat folic acid multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DNAJC19 mRNA; [Methionine deficiency co-treated more ... CTD PMID:20938992|PMID:22206623 Dnajc19 Rat folic acid increases expression ISO DNAJC19 (Homo sapiens) 6480464 Folic Acid results in increased expression of DNAJC19 mRNA CTD PMID:21867686 Dnajc19 Rat FR900359 decreases phosphorylation ISO DNAJC19 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of DNAJC19 protein CTD PMID:37730182 Dnajc19 Rat galaxolide decreases expression EXP 6480464 galaxolide results in decreased expression of DNAJC19 mRNA CTD PMID:37797914 Dnajc19 Rat glycochenodeoxycholic acid multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Dnajc19 Rat glycocholic acid multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Dnajc19 Rat glycodeoxycholic acid multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Dnajc19 Rat gold atom decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Gold results in decreased expression of DNAJC19 mRNA CTD PMID:25523186 Dnajc19 Rat gold(0) decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Gold results in decreased expression of DNAJC19 mRNA CTD PMID:25523186 Dnajc19 Rat indometacin multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Dnajc19 Rat L-methionine multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Dnajc19 Rat leflunomide decreases expression ISO DNAJC19 (Homo sapiens) 6480464 leflunomide results in decreased expression of DNAJC19 mRNA CTD PMID:28988120|PMID:29427785 Dnajc19 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of DNAJC19 mRNA CTD PMID:30047161 Dnajc19 Rat methylmercury chloride decreases expression ISO DNAJC19 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of DNAJC19 mRNA CTD PMID:28001369 Dnajc19 Rat nefazodone multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:32152650 Dnajc19 Rat nefazodone decreases expression ISO DNAJC19 (Homo sapiens) 6480464 nefazodone results in decreased expression of DNAJC19 mRNA CTD PMID:32152650 Dnajc19 Rat okadaic acid decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of DNAJC19 mRNA CTD PMID:38832940 Dnajc19 Rat ozone multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of DNAJC19 mRNA CTD PMID:35430440 Dnajc19 Rat paracetamol affects expression ISO Dnajc19 (Mus musculus) 6480464 Acetaminophen affects the expression of DNAJC19 mRNA CTD PMID:17562736 Dnajc19 Rat paracetamol increases expression ISO DNAJC19 (Homo sapiens) 6480464 Acetaminophen results in increased expression of DNAJC19 mRNA CTD PMID:26690555 Dnajc19 Rat paracetamol decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of DNAJC19 mRNA CTD PMID:25704631 Dnajc19 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Dnajc19 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DNAJC19 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 Dnajc19 Rat phenobarbital decreases expression ISO Dnajc19 (Mus musculus) 6480464 Phenobarbital results in decreased expression of DNAJC19 mRNA CTD PMID:23091169 Dnajc19 Rat phlorizin decreases expression ISO Dnajc19 (Mus musculus) 6480464 Phlorhizin results in decreased expression of DNAJC19 mRNA CTD PMID:22538082 Dnajc19 Rat pirinixic acid multiple interactions ISO Dnajc19 (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of DNAJC19 mRNA] CTD PMID:21318169 Dnajc19 Rat pirinixic acid increases expression ISO Dnajc19 (Mus musculus) 6480464 pirinixic acid results in increased expression of DNAJC19 mRNA CTD PMID:17426115 Dnajc19 Rat pirinixic acid decreases expression ISO Dnajc19 (Mus musculus) 6480464 pirinixic acid results in decreased expression of DNAJC19 mRNA CTD PMID:21318169 Dnajc19 Rat potassium chromate multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJC19 mRNA CTD PMID:22079256 Dnajc19 Rat potassium chromate decreases expression ISO DNAJC19 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of DNAJC19 mRNA CTD PMID:22079256 Dnajc19 Rat propiconazole decreases expression ISO Dnajc19 (Mus musculus) 6480464 propiconazole results in decreased expression of DNAJC19 mRNA CTD PMID:21278054 Dnajc19 Rat silver atom decreases expression ISO Dnajc19 (Mus musculus) 6480464 Silver results in decreased expression of DNAJC19 mRNA CTD PMID:27131904 Dnajc19 Rat silver(0) decreases expression ISO Dnajc19 (Mus musculus) 6480464 Silver results in decreased expression of DNAJC19 mRNA CTD PMID:27131904 Dnajc19 Rat silver(1+) nitrate decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Silver Nitrate analog results in decreased expression of DNAJC19 mRNA CTD PMID:22831968 Dnajc19 Rat sodium arsenate multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DNAJC19 more ... CTD PMID:32525701 Dnajc19 Rat sodium arsenite decreases expression ISO DNAJC19 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of DNAJC19 mRNA CTD PMID:38568856 Dnajc19 Rat sodium arsenite multiple interactions ISO DNAJC19 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC19 more ... CTD PMID:39836092 Dnajc19 Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of DNAJC19 mRNA CTD PMID:30047161 Dnajc19 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of DNAJC19 mRNA CTD PMID:31150632 Dnajc19 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DNAJC19 mRNA] CTD PMID:31150632 Dnajc19 Rat thalidomide decreases expression ISO Dnajc19 (Mus musculus) 6480464 Thalidomide results in decreased expression of DNAJC19 mRNA CTD PMID:26217789 Dnajc19 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of DNAJC19 mRNA CTD PMID:34492290 Dnajc19 Rat thiram decreases expression ISO DNAJC19 (Homo sapiens) 6480464 Thiram results in decreased expression of DNAJC19 mRNA CTD PMID:38568856 Dnajc19 Rat titanium dioxide decreases methylation ISO Dnajc19 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of DNAJC19 gene CTD PMID:35295148 Dnajc19 Rat toluene decreases expression EXP 6480464 Toluene results in decreased expression of DNAJC19 mRNA CTD PMID:22967744 Dnajc19 Rat triadimefon increases expression EXP 6480464 triadimefon results in increased expression of DNAJC19 mRNA CTD PMID:30047161 Dnajc19 Rat trichloroethene decreases expression ISO Dnajc19 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of DNAJC19 mRNA CTD PMID:25549359 Dnajc19 Rat triptonide decreases expression ISO Dnajc19 (Mus musculus) 6480464 triptonide results in decreased expression of DNAJC19 mRNA CTD PMID:33045310 Dnajc19 Rat tungsten increases expression ISO Dnajc19 (Mus musculus) 6480464 Tungsten results in increased expression of DNAJC19 mRNA CTD PMID:30912803 Dnajc19 Rat valproic acid increases expression ISO DNAJC19 (Homo sapiens) 6480464 Valproic Acid results in increased expression of DNAJC19 mRNA CTD PMID:23179753 Dnajc19 Rat valproic acid affects expression ISO DNAJC19 (Homo sapiens) 6480464 Valproic Acid affects the expression of DNAJC19 mRNA CTD PMID:25979313
QTLs in Region (GRCr8)
2293671 Bss44 Bone structure and strength QTL 44 10.97 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 2 105628029 150628029 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 44537979 205135428 Rat 1598865 Bp296 Blood pressure QTL 296 2.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 82947902 127947902 Rat 1354648 Bp239 Blood pressure QTL 239 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 67845370 229470703 Rat 1578772 Stresp14 Stress response QTL 14 5 0.001 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 2 84056790 132859658 Rat 1354649 Kidm17 Kidney mass QTL 17 2.9 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 2 83465462 229820014 Rat 10755499 Bp389 Blood pressure QTL 389 2.61 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 20695736 231474293 Rat 1581576 Pur7 Proteinuria QTL 7 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 2 80396178 220931218 Rat 152025242 Bw191 Body weight QTL 191 3.62 body mass (VT:0001259) 2 40306867 124537199 Rat 631198 Cm22 Cardiac mass QTL 22 4.3 0.0008 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 78269809 208420281 Rat 1302794 Stl27 Serum triglyceride level QTL 27 4.4 0.0001 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 2 27148328 145807373 Rat 1581569 Uae32 Urinary albumin excretion QTL 32 0.0001 urine protein amount (VT:0005160) urine albumin excretion rate (CMO:0000757) 2 80396178 220931218 Rat 2317886 Alcrsp23 Alcohol response QTL 23 2.4 0.63 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 2 95142371 140142371 Rat 1358901 Cm38 Cardiac mass QTL 38 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 27148328 159440891 Rat 2317058 Aia13 Adjuvant induced arthritis QTL 13 2.9 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 2 78269809 123269809 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 4265106 205135428 Rat 1358899 Kidm23 Kidney mass QTL 23 3.88 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 27148328 159440891 Rat 1358908 Bw49 Body weight QTL 49 3.36 body mass (VT:0001259) body weight (CMO:0000012) 2 27148557 159440760 Rat 1358910 Kidm27 Kidney mass QTL 27 5.77 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 27148328 159440891 Rat 1358911 Kidm28 Kidney mass QTL 28 5.42 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 27148328 159440891 Rat 1358904 Cm39 Cardiac mass QTL 39 2.26 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 27148328 159440891 Rat 1359035 Bp276 Blood pressure QTL 276 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 100807373 145807373 Rat 8662836 Vetf8 Vascular elastic tissue fragility QTL 8 0.66 thoracic aorta molecular composition trait (VT:0010568) aorta wall extracellular elastin dry weight to aorta wall extracellular collagen weight ratio (CMO:0002003) 2 106869825 151869825 Rat 1358887 Bw50 Body weight QTL 50 2.39 body mass (VT:0001259) body weight (CMO:0000012) 2 27148557 159440760 Rat 1298080 Bp163 Blood pressure QTL 163 0.02 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 67845182 205135428 Rat 8662832 Vetf7 Vascular elastic tissue fragility QTL 7 3.5 aorta elastin amount (VT:0003905) aorta wall extracellular elastin dry weight to aorta wall dry weight ratio (CMO:0002002) 2 83400752 223709938 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 44537979 205135428 Rat 2290453 Scl55 Serum cholesterol level QTL 55 2.83 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 2 28652666 139067443 Rat 2299162 Iddm32 Insulin dependent diabetes mellitus QTL 32 2.36 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 2 93602631 145807373 Rat 1358894 Kidm24 Kidney mass QTL 24 4.03 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 27148328 159440891 Rat 724534 Uae6 Urinary albumin excretion QTL 6 10 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 2 80396034 220931416 Rat 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 4.42 0.86 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 78269809 205135428 Rat 634308 Sach6 Saccharin preference QTL 6 4.9 taste sensitivity trait (VT:0001986) saccharin intake volume to total fluid intake volume ratio (CMO:0001601) 2 114384617 215381366 Rat 61392 Bp6 Blood pressure QTL 6 7 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 2 82214549 127214549 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 27148328 206613235 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 27148328 206613235 Rat 1300165 Rf9 Renal function QTL 9 3.28 kidney glomerulus integrity trait (VT:0010546) index of glomerular damage (CMO:0001135) 2 113746222 205135428 Rat 7488933 Bp368 Blood pressure QTL 368 0.004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 104957381 149957381 Rat 631507 Bp105 Blood pressure QTL 105 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 114384617 215381366 Rat 1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 4.72 0.000006 insulin secretion trait (VT:0003564) plasma insulin level (CMO:0000342) 2 117415288 205135428 Rat 2293835 Kiddil5 Kidney dilation QTL 5 3.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 44537979 159440891 Rat 1581552 Pur12 Proteinuria QTL 12 5.19 0.0009 urine total protein amount (VT:0000032) urine protein excretion rate (CMO:0000759) 2 114032149 150226270 Rat 1354622 Kidm16 Kidney mass QTL 16 3 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 2 83465462 225110681 Rat 1558653 Prcr1 Prostate cancer resistance QTL 1 5 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 2 114440891 159440891 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 47856345 205135428 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 44537979 184731399 Rat 1354594 Despr10 Despair related QTL 10 2e-06 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 2 116804572 161804572 Rat 152025206 Hrtrt23 Heart rate QTL 23 5.98 heart pumping trait (VT:2000009) 2 30219200 171802126 Rat 1354605 Rf48 Renal function QTL 48 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 2 76328396 209350714 Rat 152025204 Hrtrt22 Heart rate QTL 22 5.6 heart pumping trait (VT:2000009) 2 30219200 171802126 Rat 61438 Cia7 Collagen induced arthritis QTL 7 4.6 0.0001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 2 61051541 143746880 Rat
